GLUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Glucose Health, Inc.
Financials through Q3 FY2017, quarter ended Sep 30, 2017Last filing: 10-Q on Nov 14, 2017
$0.44+0.10 (+28.76%)
Close on Oct 19, 2026
- Market cap
- $1.82M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Glucose Health has not reported a dividend
No dividend per share appears in Glucose Health's annual filings since fiscal 2009.